Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01882153
Other study ID # SU-11232011-8727
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 2010
Est. completion date February 18, 2022

Study information

Verified date July 2023
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators will assess the efficacy of parent delivered interventions in the treatment of social and communication deficits in children with autism. By collecting information about parent and child functioning before and after intervention, the investigators will be able to determine whether the intervention is effective in improving child social communication and reducing parent stress.


Recruitment information / eligibility

Status Completed
Enrollment 104
Est. completion date February 18, 2022
Est. primary completion date February 18, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Months to 17 Years
Eligibility Inclusion Criteria for autism participants: - Children between the ages of 1.6 and 17.11 years of age - Males and females - Diagnosis of autism based on DSM-IV-TR criteria, an expert clinical evaluation, and ADOS or ADI-R if needed - Receiving or will receive a parent delivered intervention to alleviate symptoms related to their diagnosis of autistic disorder - Have a care provider that will reliably bring subjects to their chosen intervention and clinic visits, and is trustworthy to provide accurate accounts of services provided to the subject Inclusion Criteria for developmentally delayed participants: - Will have an age range between 1.6 and 17.11 years of age - Males or females - Diagnosis of a developmental delay or disorder based on DSM-IV-TR, ICD-10, and an expert clinical evaluation - Have historical evidence of significant abnormal developmental milestones as determined by neurological history - Receiving or will receive a parent delivered intervention - Have a care provider that will reliably bring subjects to their chosen intervention and clinic visits, and is trustworthy to provide accurate accounts of services provided to the subject Exclusion Criteria for autism participants: - Is medically unstable (e.g., more than one seizure a month) - Have a medical diagnosis that causes autism like symptomology (e.g., Fragile X, Down syndrome, Angelman's syndrome, tuberous sclerosis, Rett's disorder) Exclusion Criteria for developmentally delayed subjects: - Is medically unstable (e.g., more than one seizure a month) - Has a diagnosis of ASD

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Pivotal Response Training (PRT)
The behaviorally-based intervention is a treatment model that uses the principles of Applied Behavior Analysis (Koegel, Openden, Fredeen, & Koegel, 2006) to increase children's adaptive behaviors and decrease maladaptive behaviors.
PACE Therapy
The developmentally based intervention is grounded in a development theory, that focuses on child-directed interactions with warm and caring individuals that aid in acquiring missed developmental and functional milestones.
PACE and PRT Hybrid
The hybrid based treatment has an eclectic approach that incorporates both systematic (behaviorally-based) and affect-based learning (developmentally-based)that focuses on increasing children's skill development (http://www.pacificautism.org).

Locations

Country Name City State
United States Stanford University School of Medicine Stanford California

Sponsors (1)

Lead Sponsor Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in CGI-S (Clinical Global Impression - Severity) Difference from Baseline to Week 12
Primary Change in SRS (Social Responsiveness Scale) Difference from Baseline to Week 12
Primary Change in CDI (Communicative Development Survey) Score Difference from Baseline to Week 12
Primary Change in social and communication behaviors as assessed by standardized laboratory observations Difference from Baseline to Week 12
Secondary Change in VABS (Vineland Adaptive Behavior Scale) Score Difference from Baseline to Week 12
Secondary Change in social and communication behaviors as assessed from home videos Difference from Baseline to Week 12
Secondary Change in PSI (Parenting Stress Index) Score Difference from Baseline to Week 12
Secondary Change in FES (Family Empowerment Scale) Score Difference from Baseline to Week 12
Secondary Change in frequency and duration of investigation therapy Difference from Baseline to Week 12
Secondary Change in demographics data Difference from Baseline to Week 12
See also
  Status Clinical Trial Phase
Recruiting NCT03222375 - SQUEDâ„¢ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism N/A
Completed NCT02568631 - Improving Social Cognition for Adults With ASD by the Serious Game JeStiMulE Versus Controls N/A
Completed NCT02708290 - Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD
Completed NCT02369445 - Investigation of Teacher-Mediated Toilet Training Using a Manualized Moisture Alarm Intervention N/A
Completed NCT01617460 - A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder Phase 3
Completed NCT01592747 - Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine Phase 2
Completed NCT01400269 - An Evaluation of a Developmentally-Based Parent Training Program for Children With Autism N/A
Active, not recruiting NCT02442115 - Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
Completed NCT00926471 - Social Skills and Anxiety Reduction Treatment for Children and Adolescents With Autism Spectrum Disorders Phase 1
Completed NCT00365859 - Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD) Phase 3
Completed NCT00692315 - Treating Oxidative Stress in Children With Autism N/A
Completed NCT00198107 - Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism Phase 3
Completed NCT00095420 - Relationship Training for Children With Autism and Their Peers N/A
Completed NCT00027404 - Study of Fluoxetine in Adults With Autistic Disorder N/A
Recruiting NCT05910502 - Project AFECT (Autism Family Empowerment Coaching and Training Program) N/A
Completed NCT04820998 - Living in a Precarious Situation With an Autistic Child: What Are the Issues at Stake for Support in Care
Withdrawn NCT05413187 - A Trial to Assess the Efficacy and Safety of Medical Grade Cannabis in Children Diagnosed With Autism Spectrum Disorder Phase 2
Recruiting NCT02275455 - Design Of WELL Being Monitoring Systems, Application in Autism N/A
Completed NCT02766101 - Manville Moves: an Exercise Intervention for Behavioral Regulation Among Children With Behavioral Health Challenges N/A
Completed NCT01977248 - Sensorimotor Affect Relationship-based Therapy (SMART) for Children With Autism Spectrum Disorders Ages 2-12 N/A